Radiation Risks Of Interventional Fluoroscopy Examined At FDA Meeting
This article was originally published in The Gray Sheet
Executive Summary
The use of fluoroscopic imaging during interventional procedures such as cardiovascular catheterizations raises unique radiation exposure issues that must be examined apart from those for diagnostic imaging
You may also be interested in...
FDA Aims To Educate Makers Of Fluoroscopic X-Ray Systems In Its Latest Final Guidance
A new guidance document from the US FDA clarifies the agency's current thinking on targeted portions of its performance standard requirements for the X-ray systems.
FDA Says It Will Accept International Standard On Fluoroscopic Equipment
FDA plans to accept a declaration of conformity to an international standard for fluoroscopic equipment even though it does not perfectly the match the performance standard found in FDA regulations, the agency said in draft guidance.
Industry Unveils Radiation Therapy Patient Protection Effort At FDA Meeting
Manufacturers of linear accelerators and other devices for radiation oncology treatments are endorsing an industry "Radiation Therapy Readiness Check Initiative" to help prevent treatment errors